Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Moleculin Biotech, Inc. MBRX

Full chart Compare
Set alert

Price alert · MBRX

All alert types
8.88 USD +0.15 (+1.72%)

Nov 6, 2026, 9:30 AM EST

8.88 Day range 8.88
3.22 52-week range 253.00
YTD
+168.28%
1 year
-22.31%

Financial health

Altman Z-Score

-19.24 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

B-3 / 5 overall

  • DCF 4
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 4

Valuation

P/E -0.1×
FY 2016: -5.7×FY 2017: -3.5×FY 2018: -2.3×FY 2019: -2.8×FY 2020: -2.7×FY 2021: -3.1×FY 2022: -1.0×FY 2023: -0.9×FY 2024: -0.2×FY 2025: -0.1×
FY 2016 5y median -0.9× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 0.3×
FY 2016: 1.5×FY 2017: 2.0×FY 2018: 1.9×FY 2019: 2.4×FY 2020: 2.6×FY 2021: 0.6×FY 2022: 0.6×FY 2023: 1.0×FY 2024: 1.0×FY 2025: 0.3×
FY 2016 5y median 0.6× FY 2025
P/FCF -0.2×
FY 2016: -5.9×FY 2017: -4.7×FY 2018: -2.1×FY 2019: -2.2×FY 2020: -2.6×FY 2021: -2.6×FY 2022: -1.1×FY 2023: -1.1×FY 2024: -0.2×FY 2025: -0.2×
FY 2016 5y median -1.1× FY 2025
EV/EBITDA 0.1×
FY 2016: -4.6×FY 2017: -3.1×FY 2018: -1.3×FY 2019: -2.0×FY 2020: -1.6×FY 2021: 1.3×FY 2022: 0.4×FY 2023: -0.1×FY 2024: -0.1×FY 2025: 0.1×
FY 2016 5y median 0.1× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -579.8%
FY 2016: -16.9%FY 2017: -21.3%FY 2018: -46.8%FY 2019: -46.3%FY 2020: -38.5%FY 2021: -38.0%FY 2022: -91.4%FY 2023: -95.2%FY 2024: -407.9%FY 2025: -579.8%
FY 2016 5y median -95.2% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -223.6%
FY 2016: -26.2%FY 2017: -57.3%FY 2018: -83.2%FY 2019: -84.8%FY 2020: -97.0%FY 2021: -20.1%FY 2022: -55.6%FY 2023: -114.2%FY 2024: -364.0%FY 2025: -223.6%
FY 2016 5y median -114.2% FY 2025
ROIC -162.9%
FY 2016: -25.3%FY 2017: -50.1%FY 2018: -95.7%FY 2019: -79.1%FY 2020: -74.9%FY 2021: -28.5%FY 2022: -58.1%FY 2023: -94.1%FY 2024: -228.0%FY 2025: -162.9%
FY 2016 5y median -94.1% FY 2025
ROA -151.7%
FY 2016: -24.0%FY 2017: -50.3%FY 2018: -60.6%FY 2019: -52.3%FY 2020: -59.5%FY 2021: -18.9%FY 2022: -50.5%FY 2023: -77.9%FY 2024: -128.6%FY 2025: -151.7%
FY 2016 5y median -77.9% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income 5.8%
FY 2016: -426.0%FY 2017: -122.8%FY 2018: -73.6%FY 2019: -16.6%FY 2020: -12.7%FY 2021: -16.3%FY 2022: -33.4%FY 2023: 3.3%FY 2024: 10.1%FY 2025: 5.8%
FY 2016 FY 2025
EPS (diluted) 85.0%
FY 2016: -662.9%FY 2017: -32.0%FY 2018: 13.2%FY 2019: 29.3%FY 2020: 9.4%FY 2021: 66.4%FY 2022: -71.6%FY 2023: 1.0%FY 2024: 49.8%FY 2025: 85.0%
FY 2016 FY 2025
Free Cash Flow 4.8%
FY 2016: -794.0%FY 2017: -94.2%FY 2018: -71.7%FY 2019: -36.7%FY 2020: -5.2%FY 2021: -4.5%FY 2022: -46.1%FY 2023: 12.6%FY 2024: 1.4%FY 2025: 4.8%
FY 2016 FY 2025

Financial Health

Current Ratio 1.4×
FY 2016: 3.9×FY 2017: 3.7×FY 2018: 2.1×FY 2019: 3.8×FY 2020: 5.9×FY 2021: 20.0×FY 2022: 9.5×FY 2023: 3.9×FY 2024: 1.0×FY 2025: 1.4×
FY 2016 5y median 3.9× FY 2025
Quick Ratio 1.4×
FY 2016: 3.9×FY 2017: 3.7×FY 2018: 2.1×FY 2019: 3.8×FY 2020: 5.9×FY 2021: 20.0×FY 2022: 9.5×FY 2023: 3.9×FY 2024: 1.0×FY 2025: 1.4×
FY 2016 5y median 3.9× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.1×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.3×
FY 2016: 1.2×FY 2017: 0.9×FY 2018: 0.5×FY 2019: 0.8×FY 2020: 0.8×FY 2021: 4.5×FY 2022: 1.5×FY 2023: 0.8×FY 2024: 0.2×FY 2025: 0.3×
FY 2016 5y median 0.8× FY 2025
Interest Coverage 0.0×
FY 2016: -89.9×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31